Does RITUXIMAB-ABBS Cause Systemic scleroderma? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Systemic scleroderma have been filed in association with RITUXIMAB-ABBS. This represents 0.3% of all adverse event reports for RITUXIMAB-ABBS.
11
Reports of Systemic scleroderma with RITUXIMAB-ABBS
0.3%
of all RITUXIMAB-ABBS reports
0
Deaths
4
Hospitalizations
How Dangerous Is Systemic scleroderma From RITUXIMAB-ABBS?
Of the 11 reports, 4 (36.4%) required hospitalization.
Is Systemic scleroderma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-ABBS Cause?
Off label use (2,167)
Intentional product use issue (273)
Dyspnoea (208)
Pain (205)
Rheumatoid arthritis (202)
Intentional dose omission (196)
Fatigue (195)
Drug ineffective (186)
Hypertension (183)
Infusion related reaction (183)
What Other Drugs Cause Systemic scleroderma?
RITUXIMAB (54)
CYCLOPHOSPHAMIDE (53)
MACITENTAN (52)
DOCETAXEL (49)
METHOTREXATE (45)
MYCOPHENOLATE MOFETIL (44)
FLUOROURACIL (34)
SELEXIPAG (34)
TREPROSTINIL (34)
BOSENTAN (30)
Which RITUXIMAB-ABBS Alternatives Have Lower Systemic scleroderma Risk?
RITUXIMAB-ABBS vs RITUXIMAB-ARRX
RITUXIMAB-ABBS vs RITUXIMAB-PVVR
RITUXIMAB-ABBS vs RIVAROXABAN
RITUXIMAB-ABBS vs RIVASTIGMINE
RITUXIMAB-ABBS vs RIVOTRIL